By Application: T2DM dominates, Obesity growing fastest Type 2 Diabetes Mellitus maintained the dominant application position in the GLP-1 Receptor Agonist Market in 2025, driven by the large established prescriber base, comprehensive insurance coverage for diabetes indications, and the longer clinical history of GLP-1 therapy in diabetes management that has built physician comfort and treatment guideline endorsement
However, regulations differ by region
Some fortified foods, dietary supplements, and medications contain a synthetic version of vitamin B12
When reconstituting peptides, it is important to know how much bacteriostatic water to use
The GLP-1 weight loss program is more than just a diet
L-carnitine is highly hygroscopic, possesses good water solubility and water absorption capacity, and can withstand temperatures above 200C